Product Information
SEGLUROMET 7.5-500 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $5.7054 per EA under NDC 00006537003. Its NADAC has been published 323 times since Jun 17, 2020.
FDA first approved this application on Dec 19, 2017.
Strength
7.5; 500 mg/1; mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006537003
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA209806FDA Approved
12/19/2017
On Market Since
12/19/2017
Pharmacological Classes
Price Statistics
The NADAC for SEGLUROMET 7.5-500 MG TABLET has been published 323 times since Jun 17, 2020, and over the history we have for it it has risen 20.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7054 per EA |
|---|---|
| All-time high | $5.7718 (May 15, 2024) |
| All-time low | $4.7279 (Jun 17, 2020) |
| 52-week high | $5.7363 |
| 52-week low | $5.6929 |
| Median price | $5.4582 |
| Average price | $5.3857 |
| Largest weekly change | +5.0% (Jan 18, 2023) |
| Weeks tracked | 323 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SEGLUROMET 7.5-500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEGLUROMET 7.5-500 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $5.7054 per EA (NDC 00006537003), effective Aug 19, 2026.
How has the price of SEGLUROMET 7.5-500 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEGLUROMET 7.5-500 MG TABLET has risen 20.7%. It has been tracked across 323 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for SEGLUROMET 7.5-500 MG TABLET?
Since Jun 17, 2020, the NADAC for SEGLUROMET 7.5-500 MG TABLET has ranged from a low of $4.7279 (Jun 17, 2020) to a high of $5.7718 (May 15, 2024), with a median of $5.4582 per EA.
Are there cheaper alternatives to SEGLUROMET 7.5-500 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SEGLUROMET 7.5-500 MG TABLET, is $5.4582 per EA — about 4% below SEGLUROMET 7.5-500 MG TABLET.
Who manufactures SEGLUROMET 7.5-500 MG TABLET?
SEGLUROMET 7.5-500 MG TABLET (NDC 00006537003) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.